You are viewing the site in preview mode

Skip to main content

Advertisement

Fig. 1 | BMC Infectious Diseases

Fig. 1

From: Analysis of patients with diabetes and complicated intra-abdominal infection or complicated urinary tract infection in phase 3 trials of ceftolozane/tazobactam

Fig. 1

Clinical cure (cIAI) and composite cure (cUTI) in patients with and without diabetes at test-of-cure in cIAI (MITT population) and cUTI (mMITT population) (a). Clinical cure at test-of-cure in cIAI (MITT population) (b). Composite cure at test-of-cure in cUTI (mMITT population) (c). Values above brackets indicate treatment difference (95% confidence intervals)

Back to article page